Close Menu

Wellcome Trust

The funding will support PacBio's effort to launch its SMRT sequencing system in the second half of 2010, and will also serve as a financial "buffer" as the company looks to pursue an initial public offering or other large-scale financing effort some time next year.

Agilent will launch an automated liquid-handling workflow by early October, and will add million-feature arrays in its high-density G3 format for expression profiling and location analysis studies within the next six to nine months.

Research groups doing sequencing studies and GWAS in cardiovascular disease, obesity, and type 2 diabetes are working on a project with Illumina to develop a single chip, called Metabo-Chip, that can detect up to 50,000 new and rare SNPs associated with various diseases, according to NHGRI scientist Michael Erdos.

Moving Target: CNVs in Disease

Premium

More and more research is linking CNVs to disease. It's not only changing the way scientists study disease, but also how clinicians diagnose it.

Cell Biosciences will use funding to pursue commercialization of its proteomics analysis system.

Agilent's Human CNV Association 2x105K microarray, based on a design by the Wellcome Trust Case Control Consortium, is the company's second catalog CNV chip and was designed for studying associations between genomic CNVs and disease.

Beyond the SNP

Premium

Genome-wide association studies have put forward a vast number of SNPs associated with disease. Once you have those SNPs, the search is on for the causal variant.

Pages

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.